» Authors » Hanno Ulmer

Hanno Ulmer

Explore the profile of Hanno Ulmer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 329
Citations 6495
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lanser L, Polzl G, Messner M, Ungericht M, Zaruba M, Hirsch J, et al.
ESC Heart Fail . 2025 Feb; PMID: 39930934
Aims: Iron is essential to maintain cellular energy metabolism in the myocardium. Impaired cellular iron availability negatively affects myocardial physiology and can aggravate heart failure (HF). Iron deficiency (ID) is...
2.
Pichler R, Fritz J, Maier S, Hassler M, Krauter J, D Andrea D, et al.
Cancer Immunol Immunother . 2024 Dec; 74(1):30. PMID: 39708183
Background: Immune checkpoint inhibitors (ICIs) are an important therapeutic pillar in metastatic urothelial carcinoma (mUC). The occurrence of immune-related adverse events (irAEs) appears to be associated with improved outcomes in...
3.
Burtscher J, Kopp M, Klimont J, Ulmer H, Strasser B, Burtscher M
BMC Public Health . 2024 Oct; 24(1):2843. PMID: 39415183
Background: The amount of regular physical activity (PA) can modulate the prevalence of traditional risk factors for cardiovascular disease (CVD) such as obesity, systemic hypertension, hypercholesterolemia, and type 2 diabetes...
4.
Kreutziger J, Ulmer H, Fries D
N Engl J Med . 2024 Aug; 391(8):772-773. PMID: 39167816
No abstract available.
5.
Polzl L, Thielmann M, Sterzinger P, Nagele F, Hirsch J, Graber M, et al.
Ann Thorac Surg . 2024 Jul; 119(1):120-128. PMID: 38964702
Background: The impact of sex-differences on the release of cardiac biomarkers after coronary artery bypass grafting (CABG) remains unknown. The aim of our study was to (1) investigate the impact...
6.
Lehner G, Tobiasch A, Perschinka F, Mayerhofer T, Waditzer M, Haller V, et al.
Sci Rep . 2024 Jun; 14(1):14468. PMID: 38914630
Coagulopathy, microvascular alterations and concomitant organ dysfunctions are hallmarks of sepsis. Attempts to attenuate coagulation activation with an inhibitor of tissue factor (TF), i.e. tissue factor pathway inhibitor (TFPI), revealed...
7.
Holfeld J, Nagele F, Polzl L, Engler C, Graber M, Hirsch J, et al.
Eur Heart J . 2024 Jun; 45(29):2634-2643. PMID: 38898573
Background And Aims: In chronic ischaemic heart failure, revascularisation strategies control symptoms but are less effective in improving left ventricular ejection fraction (LVEF). The aim of this trial is to...
8.
Lanser L, Poelzl G, Messner M, Ungericht M, Zaruba M, Hirsch J, et al.
J Am Heart Assoc . 2024 Apr; 13(9):e032540. PMID: 38639356
Background: Iron deficiency (ID) is a frequent comorbidity in patients with acute (AHF) and chronic heart failure (CHF) associated with morbidity and death. We aimed to better characterize iron homeostasis...
9.
Brozek W, Clemens P, Ulmer H, Haring N, Concin H, Zitt E, et al.
Cancers (Basel) . 2024 Apr; 16(7). PMID: 38610961
Background: whether screening for skin cancer affects melanoma-specific mortality in a population-based setting remains unclear. Methods: in this population-based cohort study, we characterized and evaluated a skin cancer prevention program...
10.
Abfalterer H, Ruttmann-Ulmer E, Grimm M, Feuchtner G, Maier S, Ulmer H, et al.
Interdiscip Cardiovasc Thorac Surg . 2024 Mar; 38(4). PMID: 38514397
Latest research has indicated a potential adverse effect on graft patency rates and clinical outcomes with skeletonizing the left internal thoracic artery. We aim to provide a prospective, randomized, multicentre...